Cambridge Investment Research Advisors’s Franklin FTSE United Kingdom ETF FLGB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$461K Sell
13,076
-6,730
-34% -$241K ﹤0.01% 3043
2026
Q1
$688K Sell
19,806
-1,066
-5% -$37.5K ﹤0.01% 2513
2025
Q4
$704K Buy
20,872
+563
+3% +$18.5K ﹤0.01% 2415
2025
Q3
$656K Buy
20,309
+1,457
+8% +$45.8K ﹤0.01% 2423
2025
Q2
$577K Sell
18,852
-1,986
-10% -$58.6K ﹤0.01% 2408
2025
Q1
$597K Buy
20,838
+81
+0.4% +$2.26K ﹤0.01% 2262
2024
Q4
$544K Sell
20,757
-6,575
-24% -$180K ﹤0.01% 2359
2024
Q3
$780K Sell
27,332
-694
-2% -$19.1K ﹤0.01% 2052
2024
Q2
$737K Buy
+28,026
New +$751K ﹤0.01% 1995

Other funds holding FLGB

Cambridge Investment Research Advisors's FLGB Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Franklin FTSE United Kingdom ETF (FLGB) stake by 34% in Q2 2026, selling an estimated $241K and leaving 13,076 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

Cambridge Investment Research Advisors first reported a position in FLGB in Q2 2024 and has held it in 9 quarters since. The position peaked at $780K in Q3 2024. 45 funds tracked by Wall St. Rank hold FLGB as of Q2 2026.

  • Cambridge Investment Research Advisors held 13,076 shares of Franklin FTSE United Kingdom ETF worth $461K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 6,730 Franklin FTSE United Kingdom ETF shares in Q2 2026, an estimated $241K.
  • Franklin FTSE United Kingdom ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3043 holding.
  • Cambridge Investment Research Advisors first reported a position in Franklin FTSE United Kingdom ETF in Q2 2024 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's Franklin FTSE United Kingdom ETF position peaked at $780K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held Franklin FTSE United Kingdom ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.